Adetunji T. Toriola, MD, PhD

Education

Medical School: MD, Obafemi Awolowo University, Ile-Ife, Nigeria, 1998
DA (Diploma in Anesthesia), West African College of Surgeons, 2004

Graduate School

MPH (Master of Science in Public Health), University of Kuopio, Kuopio, Finland, 2007
PhD (Epidemiology), University of Tampere, Tampere, Finland, 2011

Post Doctoral Education

Postdoctoral Fellowship: German Cancer Research Center (DKFZ), Heidelberg, Germany, 2011-2012

Research Interests

Dr. Toriola’s research interest focuses on the use of biomarkers to investigate the associations of energetics, hormones and inflammation with cancer risk and survival. He is especially interested in the interplay between inflammation and insulin resistance in cancer risk and mortality and the translational importance of such relationships. He has taken leading roles in studies conducted within large cohorts such as the Women’s Health Initiative Observational Study, Finnish Maternity Cohort, Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial and Kuopio Ischemic Heart Disease Risk Factor Study.

Contact Information

660 S. Euclid Avenue
Campus Box 8100
St. Louis, MO 63110
(314) 268-2668
a.toriola@wustl.edu

PubMed page for Dr. Toriola